Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-25-113402
Filing Date
2025-05-06
Accepted
2025-05-06 08:10:44
Documents
16

Document Format Files

Seq Description Document Type Size
1 424B5 d899199d424b5.htm 424B5 358753
2 EX-FILING FEES d899199dexfilingfees.htm   iXBRL EX-FILING FEES 42169
3 GRAPHIC g899199g01x01.jpg GRAPHIC 54357
4 GRAPHIC g899199g23x23.jpg GRAPHIC 57909
5 GRAPHIC g899199g99p03.jpg GRAPHIC 51694
  Complete submission text file 0001193125-25-113402.txt   756703

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT d899199dexfilingfees_htm.xml XML 6290
Mailing Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451
Business Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

EIN.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-269707 | Film No.: 25915334
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)